|
ES2994006T3
(en)
|
2021-09-17 |
2025-01-16 |
Flagship Pioneering Innovations Vi Llc |
Compositions and methods for producing circular polyribonucleotides
|
|
CN114214237B
(zh)
*
|
2021-12-23 |
2023-06-16 |
南京大学 |
一种洗脱细胞表面吸附纳米颗粒的方法
|
|
CN119110847A
(zh)
*
|
2022-01-11 |
2024-12-10 |
北京大学 |
针对sars-cov-2变体的环状rna疫苗及其使用方法
|
|
WO2023141586A1
(en)
*
|
2022-01-21 |
2023-07-27 |
Orna Therapeutics, Inc. |
Systemic administration of circular rna polynucleotides encoding muscle proteins or protein complexes
|
|
CN118871134A
(zh)
*
|
2022-03-21 |
2024-10-29 |
生物探险有限公司 |
用于增强蛋白质表达的内部核糖体进入位点（IRES）、质粒载体和环状mRNA
|
|
US12297285B2
(en)
*
|
2022-06-24 |
2025-05-13 |
Orna Therapeutics, Inc. |
Circular RNA encoding chimeric antigen receptors targeting BCMA
|
|
CN116064531B
(zh)
*
|
2022-09-07 |
2024-04-02 |
昆明理工大学 |
一种抑制cvb5病毒复制的长链非编码rna及应用
|
|
CN120390656A
(zh)
|
2022-11-08 |
2025-07-29 |
欧纳医疗公司 |
环状rna组合物
|
|
AU2023398825A1
(en)
|
2022-12-15 |
2025-06-26 |
Orna Therapeutics, Inc. |
Circular rna compositions and methods
|
|
WO2024192420A1
(en)
|
2023-03-15 |
2024-09-19 |
Flagship Pioneering Innovations Vi, Llc |
Compositions comprising polyribonucleotides and uses thereof
|
|
EP4680276A1
(en)
|
2023-03-15 |
2026-01-21 |
Flagship Pioneering Innovations VI, LLC |
Immunogenic compositions and uses thereof
|
|
KR20240159310A
(ko)
*
|
2023-04-28 |
2024-11-05 |
주식회사 메디치바이오 |
신규한 이온화지질을 이용한 지질나노입자 조성물
|
|
WO2024205657A2
(en)
*
|
2023-03-29 |
2024-10-03 |
Orna Therapeutics, Inc. |
Lipids and lipid nanoparticle compositions for delivering polynucleotides
|
|
CN121358499A
(zh)
|
2023-03-30 |
2026-01-16 |
Ose免疫疗法 |
靶向活化的免疫细胞以表达免疫细胞增强分子的基于脂质的纳米粒及其用途
|
|
AU2024254671A1
(en)
|
2023-03-30 |
2025-10-02 |
Ose Immunotherapeutics |
Method of synthesis of targeted lipid nanoparticle and uses thereof
|
|
WO2024220752A2
(en)
|
2023-04-19 |
2024-10-24 |
Sail Biomedicines, Inc. |
Rna therapeutic compositions
|
|
WO2024220712A2
(en)
|
2023-04-19 |
2024-10-24 |
Sail Biomedicines, Inc. |
Vaccine compositions
|
|
EP4698150A1
(en)
|
2023-04-19 |
2026-02-25 |
Sail Biomedicines, Inc. |
Delivery of polynucleotides from lipid nanoparticles comprising rna and ionizable lipids
|
|
WO2024233308A2
(en)
|
2023-05-05 |
2024-11-14 |
Orna Therapeutics, Inc. |
Circular rna compositions and methods
|
|
US12311033B2
(en)
|
2023-05-31 |
2025-05-27 |
Capstan Therapeutics, Inc. |
Lipid nanoparticle formulations and compositions
|
|
WO2025006613A1
(en)
*
|
2023-06-27 |
2025-01-02 |
Hopewell Therapeutics, Inc. |
Lipid nanoparticles for cancer immunotherapy
|
|
WO2025007148A1
(en)
|
2023-06-30 |
2025-01-02 |
Orna Therapeutics, Inc. |
Polymer lipid nanoparticle compositions for delivering circular polynucleotides
|
|
WO2025036467A1
(en)
*
|
2023-08-17 |
2025-02-20 |
Wuhan University |
Circular rna with increased stability and expression
|
|
WO2025049690A1
(en)
|
2023-08-29 |
2025-03-06 |
Orna Therapeutics, Inc. |
Circular polyethylene glycol lipids
|
|
AU2024335327A1
(en)
|
2023-09-01 |
2026-03-26 |
Renagade Therapeutics Management Inc. |
Gene editing systems, compositions, and methods for treatment of vexas syndrome
|
|
WO2025101501A1
(en)
|
2023-11-07 |
2025-05-15 |
Orna Therapeutics, Inc. |
Circular rna compositions
|
|
WO2025106915A1
(en)
|
2023-11-17 |
2025-05-22 |
Sail Biomedicines, Inc. |
Circular polyribonucleotides encoding glucagon-like peptide 1 (glp-1) and uses thereof
|
|
WO2025106930A1
(en)
|
2023-11-17 |
2025-05-22 |
Sail Biomedicines, Inc. |
Circular polyribonucleotides encoding glucagon-like peptide 2 (glp-2) and uses thereof
|
|
WO2025117969A1
(en)
|
2023-12-01 |
2025-06-05 |
Orna Therapeutics, Inc. |
Process for manufacturing lipid nanoparticles
|
|
WO2025128871A2
(en)
|
2023-12-13 |
2025-06-19 |
Renagade Therapeutics Management Inc. |
Lipid nanoparticles comprising coding rna molecules for use in gene editing and as vaccines and therapeutic agents
|
|
WO2025133115A1
(en)
|
2023-12-21 |
2025-06-26 |
Ose Immunotherapeutics |
Lipid-based nanoparticles comprising il-35
|
|
WO2025149040A1
(zh)
*
|
2024-01-11 |
2025-07-17 |
深圳近邻生物科技有限公司 |
一种通用的且无"scar"的RNA环化方法
|
|
WO2025155753A2
(en)
|
2024-01-17 |
2025-07-24 |
Renagade Therapeutics Management Inc. |
Improved gene editing system, guides, and methods
|
|
WO2025166238A1
(en)
|
2024-01-31 |
2025-08-07 |
Orna Therapeutics, Inc. |
Fast-shedding polyethylene glycol lipids
|
|
WO2025179198A1
(en)
|
2024-02-23 |
2025-08-28 |
Sail Biomedicines, Inc. |
Circular polyribonucleotides and unmodified linear rnas with reduced immunogenicity
|
|
WO2025218812A1
(en)
*
|
2024-04-19 |
2025-10-23 |
Shanghai Circode Biomed Co., Ltd. |
Novel internal ribosome entry sites and uses thereof
|
|
WO2025250751A1
(en)
|
2024-05-31 |
2025-12-04 |
Orna Therapeutics, Inc. |
Circular rna compositions and methods
|
|
CN118703488A
(zh)
*
|
2024-06-20 |
2024-09-27 |
毕昇(北京)生物科技有限公司 |
一种环状rna的纯化方法
|
|
WO2026003582A2
(en)
|
2024-06-27 |
2026-01-02 |
Axelyf ehf. |
Lipids and lipid nanoparticles
|
|
WO2026006593A1
(en)
|
2024-06-28 |
2026-01-02 |
Orna Therapeutics, Inc. |
Synthetic internal ribosome entry sites
|
|
WO2026072709A1
(en)
|
2024-09-25 |
2026-04-02 |
Orna Therapeutics, Inc. |
Chimeric antigen receptors targeting bcma
|
|
WO2026068705A1
(en)
|
2024-09-26 |
2026-04-02 |
Ose Immunotherapeutics |
Lipid-based nanoparticles comprising non-glycosylated fc domains and uses thereof
|
|
CN119876152A
(zh)
*
|
2025-02-10 |
2025-04-25 |
毕昇(北京)生物科技有限公司 |
一种环状rna、嵌合抗原受体t细胞和构建方法及应用
|